Number of the records: 1
syndróm anticholinergický
SYS d064807 LBL 00000cx^^^2200181-^^45^^ 005 20240119201531.7 100 $a 20140101asloy0103 ba0 152 $b mesh 250 $a syndróm anticholinergický $x BL $x CF $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 2014 $8 eng 300 1-
$a Cholinergic Antagonists (1995-2013) $8 eng 330 1-
$a Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome. $8 eng 450 $a syndróm anticholinergický centrálny $5 e $8 slo 450 $a syndróm anticholinergický periférny $5 e $8 slo 550 $3 sllk_un_auth*d018680 $Y Cholinergic Antagonists $5 B $a antagonisty cholínergické 550 $3 sllk_un_auth*d018680 $Y Cholinergic Antagonists $5 F $a antagonisty cholínergické 686 $a C25.100.311 750 $a Anticholinergic Syndrome $8 eng 801 -0
$a SK $b BA006 $c 20140127 801 -0
$a SK $b BA006 $c 20140221 801 -2
$a SK $b BA006 $c 20221010 801 -2
$a SK $b BA006 $c 20230510 980 $x M
Number of the records: 1